Form EFFECT CNS Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 26, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- College H.U.N.K.S. Hauling Junk & Moving® Continues National Expansion with New Franchise Agreement in Midland, MI
- Burford Perry Earns Repeat Chambers USA Honors as Houston Trial Boutique Continues Run of Big-Case Wins
- Washington AI Network Hosts AI Honors Gala, Honors Seven American Leaders in Artificial Intelligence
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
